Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Frontotemporal Dementia Management

Non-Pharmacological Management

  • The American Geriatrics Society recommends non-pharmacological approaches as first-line treatment for behavioral and psychological symptoms of dementia (BPSD) in FTD, with goals including prevention of symptoms, symptom relief, and reduction of caregiver distress 1
  • Occupational therapy, which optimizes performance by enabling participation in desired activities, is supported by moderate evidence for improvements in activities of daily living (ADL), quality of life, and reductions in problem behaviors 2
  • The person-environment-occupation model should be used to guide occupational therapy, focusing on retraining normal movement within functional activities and graded reintroduction to daily activities 3
  • Communication interventions, including direct treatments like language stimulation tasks and indirect treatments involving training family and professional caregivers, are essential for early recognition of communication problems in FTD 2
  • Multisensory treatments, such as Snoezelen, can address sensory deprivation and are suitable for moderate dementia stages 2
  • Music therapy, including both active and receptive interventions, can reduce depression and overall behavioral problems, with some studies showing effectiveness in reducing agitation, anxiety, and other neuropsychiatric symptoms 2

Pharmacological Management

  • Antipsychotic medications, such as atypical antipsychotics, may be considered for severe behavioral disturbances but should be used with caution, and only when non-pharmacological approaches and SSRIs have failed 1
  • Cholinesterase inhibitors and memantine have not shown consistent positive effects in FTD, with memantine showing discouraging results in clinical trials 4

Integrated Care Approach

  • A multidisciplinary team involving neurologists, psychiatrists, speech therapists, occupational therapists, and caregivers is necessary for comprehensive management of FTD, with regular support and education for caregivers being critical throughout the disease course 5, 4
  • Caregivers of individuals with FTD experience high levels of distress and depression, and training them in management strategies is essential for both patient outcomes and caregiver wellbeing 1, 6
  • Anticipatory guidance should prepare caregivers for disease progression and changing needs, with stage-specific education and expectations helping caregivers adapt to changing needs 4

Common Pitfalls and Caveats

  • Relying primarily on pharmacological approaches when non-pharmacological strategies should be first-line can be detrimental to patient care 1
  • Inadequate caregiver education and support can lead to poor management outcomes, highlighting the importance of regular reassessment and adaptation to changing needs 1, 4, 7